glp 1 pill novo nordisk launches Wegovy weight-loss in US, triggering price war | Pharmaceuticals industry FDA Approves New Weight Loss

Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial

Diabetologia 58(8):17591768

Z79.4 covers long-term insulin use

Demand has significantly outstripped supply, with Novo Nordisk even limiting new prescriptions in the US due to manufacturing constraints

Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding

These pathways are typically assessed using phosphorylation assays, metabolic flux analysis, and gene expression profiling in adipose and related tissues